DeepMed Research

Temple University-of the Commonwealth System of Higher Education

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Nurturing Needs Study: Parenting Food Motivated Children

Not Applicable

Recruiting

Conditions: Parenting
Eating Behavior
Pediatric Obesity
Diet, Healthy

Interventions: Other: Measurement

First Posted Date: 2023-11-01

Last Posted Date: 2025-03-26

Lead Sponsor: Temple University

Target Recruit Count: 600

Registration Number: NCT06111040

Locations: 🇺🇸
USDA/ARS Children's Nutrition Research Center, Houston, Texas, United States
🇺🇸
Temple University - Center for Obesity Research and Education, Philadelphia, Pennsylvania, United States

Food for Thought: Executive Functioning Around Eating Among Children

Not Applicable

Recruiting

Conditions: Child Obesity
Appetitive Behavior
Eating Behavior
Self-regulation

First Posted Date: 2023-10-30

Last Posted Date: 2025-04-10

Lead Sponsor: Temple University

Target Recruit Count: 125

Registration Number: NCT06108128

Locations: 🇺🇸
Temple University, Philadelphia, Pennsylvania, United States

Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder

Phase 4

Recruiting

Conditions: Schizo Affective Disorder
Schizophrenia Agitation
Dexmedetomidine
Bipolar Disorder

Interventions: Drug: Lorazepam 2 MG/ML
Drug: Dexmedetomidine

First Posted Date: 2023-10-23

Last Posted Date: 2023-10-23

Lead Sponsor: Temple University

Target Recruit Count: 32

Registration Number: NCT06093451

Locations: 🇺🇸
Temple University Episcopal Hospital, Philadelphia, Pennsylvania, United States

Biological Effects of Quercetin in COPD Phase II

Phase 2

Recruiting

Conditions: Chronic Obstructive Pulmonary Disease
Emphysema
Chronic Bronchitis With Airway Obstruction

Interventions: Drug: Quercetin 500 MG
Drug: Quercetin 1000 mg
Drug: Placebo

First Posted Date: 2023-08-21

Last Posted Date: 2024-04-08

Lead Sponsor: Temple University

Target Recruit Count: 30

Registration Number: NCT06003270

Locations: 🇺🇸
Nathaniel Marchetti, Philadelphia, Pennsylvania, United States

Forging Sustainable Solutions for HIV Continuity of Care Through Medical-legal Partnerships

Phase 1

Recruiting

Conditions: Organizational Partnerships for Healthy Living
Standard of Care

Interventions: Behavioral: Organizational Partnerships for Healthy Living
Behavioral: Standard of Care

First Posted Date: 2023-06-22

Last Posted Date: 2023-06-23

Lead Sponsor: Temple University

Target Recruit Count: 200

Registration Number: NCT05912842

Locations: 🇺🇸
TPAC, Philadelphia, Pennsylvania, United States

Clavulanic Acid for the Treatment of Cocaine Use Disorder

Phase 2

Active, not recruiting

Conditions: Cocaine Dependence

Interventions: Drug: Clavulanic Acid Only Product
Drug: Placebo

First Posted Date: 2022-09-30

Last Posted Date: 2024-05-02

Lead Sponsor: Temple University

Target Recruit Count: 65

Registration Number: NCT05562349

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
MUSC, Charleston, South Carolina, United States

The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)

Not Applicable

Recruiting

Conditions: Hypertension
Pregnancy Related
Obesity
Racism

Interventions: Behavioral: COH
Behavioral: COH+

First Posted Date: 2022-08-12

Last Posted Date: 2024-12-05

Lead Sponsor: Temple University

Target Recruit Count: 432

Registration Number: NCT05499507

Locations: 🇺🇸
Temple University/Temple Health, Philadelphia, Pennsylvania, United States

Machine Learning to Reduce Hypertension Treatment Clinical Inertia

Not Applicable

Not yet recruiting

Conditions: Hypertension

Interventions: Other: Predicted uncontrolled BP status (yes/no) at follow up visit, derived using a machine learning algorithm

First Posted Date: 2022-06-06

Last Posted Date: 2025-04-10

Lead Sponsor: Temple University

Target Recruit Count: 50

Registration Number: NCT05406336

Immunological Basis for Mepolizumab Activity in COPD

Phase 2

Not yet recruiting

Conditions: COPD

Interventions: Drug: Mepolizumab 100 MG

First Posted Date: 2022-04-11

Last Posted Date: 2023-04-07

Lead Sponsor: Temple University

Target Recruit Count: 30

Registration Number: NCT05320939

Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury

Phase 2

Recruiting

Conditions: Spinal Cord Injuries

Interventions: Behavioral: WI program
Behavioral: WI Program Reminder
Behavioral: JITAI Goal Setting
Behavioral: JITAI physical activity message
Other: Notification EMA
Other: End of day EMA
Other: Wake up time EMA
Other: Weekly PA Information
Other: Daily PA Information

First Posted Date: 2022-04-08

Last Posted Date: 2024-07-24

Lead Sponsor: Temple University

Target Recruit Count: 196

Registration Number: NCT05317832

Locations: 🇺🇸
Temple University, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy